SCHEMBL5773311

SCHEMBL5773311

CCOP(=O)(Cc1ccc(NC(=O)CCc2cnoc2-c2ccc(Cl)c(F)c2)cc1)OCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 2/20 0.38
MAPT P10636 7/20 0.37
LMNA P02545 4/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
MAPK1 P28482 3/20 0.37
GLA P06280 1/20 0.37
LTA4H P09960 1/20 0.36
EPHX2 P34913 1/20 0.36
PTK2 Q05397 1/20 0.36
ENTPD1 P49961 1/20 0.35
TSHR P16473 2/20 0.35
MAPK10 P53779 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ANO1 Q5XXA6 1/20 0.35
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5772702 0.93 MEN1 (0.39) BTKMAPTLMNAMEN1KMT2A
SCHEMBL5773241 0.93 BTK (0.39) BTKMAPTLMNAMEN1KMT2A
SCHEMBL5774284 0.92 MAPT (0.37) MAPTLMNAMEN1KMT2AMAPK1
SCHEMBL5776568 0.90 LMNA (0.38) BTKMAPTLMNAMEN1KMT2A
SCHEMBL5774530 0.89 BTK (0.38) BTKMAPTLMNAMEN1KMT2A
SCHEMBL5771169 0.88 LTA4H (0.45) MAPTLMNAMEN1KMT2AMAPK1
SCHEMBL5771359 0.88 MEN1 (0.40) BTKMAPTLMNAMEN1KMT2A
SCHEMBL5777014 0.88 MEN1 (0.46) BTKMAPTLMNAMEN1KMT2A
SCHEMBL5771814 0.87 MAPT (0.40) BTKMAPTLMNAMEN1KMT2A
SCHEMBL5777451 0.86 MEN1 (0.41) MAPTLMNAMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR BTK 1842/4885MAPT 4701/4885LMNA 2770/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 BTK 2179/4885MAPT 4763/4885LMNA 2605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.